The International Day for Clean Blue Skies emphasizes the critical importance of clean air and its impact on health and the environment. This day serves as a reminder of the urgent need to reduce air pollution, which is a major contributor to multiple health conditions. Healthcare professionals can help mitigate the adverse health effects of air pollution and support our global collective efforts to help the environment. Participants will learn about the latest research on the impact of air quality on respiratory health, explore the innovative #Care4EveryBreath programme, and discover actionable strategies for pharmacists to support climate change efforts. Join us to understand how healthcare professionals can lead the way in promoting a healthier, sustainable future.

Pharmacists play a vital role in Everyday Care, enhancing patient outcomes and fostering healthier communities. Join the CPD-accredited webinar, 'Everyday Care Matters: Empowering Pharmacists for the Future of Healthcare,' on 21 September 2024, from 14:00–16:00 SGT (UTC+8). Don't miss out as five expert speakers dive into various aspects of Everyday Care, offering insights and practical tips for pharmacists from across the Asia-Pacific region. 

To address the need for efficient RNA delivery beyond the liver, my lab designs inhalable, biocompatible nanocarriers for siRNA delivery to the lung. While siRNA drugs typically target the liver, the lung presents undruggable targets that RNA therapeutics could address. Nebulizable nanocarriers for pulmonary RNA administration can extend delivery beyond the liver. siRNA therapeutics are encapsulated in lipid nanoparticles (LNPs) or administered as GalNac-conjugates to protect RNA and facilitate membrane delivery. However, approved LNPs pose immunogenic risks, primarily target the liver, and offer low drug loading. Additionally, lipid-based carriers lack stability in lung surfactant and under nebulization stresses. To overcome these issues, we design polymer-based siRNA formulations.

Moderator: - Mathew Cherian, Consultant, USA

Co-moderator: - Nikolina Biskic, Regulatory Affairs Manager, Switzerland

Panellists: - Olivia Merkel, Professor of Drug Delivery Ludwig Maxmillian University (LMU), Munich, Germany

Digital health has revolutionized clinical practice, necessitating that pharmacists become adept at leveraging, developing, and benefiting from emerging technologies. Highlighting this need, the 2021 FIP report underscored the importance of integrating digital skills training into pharmacy education through well-designed courses, materials, and hands-on experiences. In response, the Academic Pharmacy Section, alongside the FIP Provision and Partnerships programme and several other FIP groups, initiated a ONEFIP project to overhaul the original digital health in pharmacy online course. This revamped, comprehensive course is specifically designed for educators and practitioners. At this event, we will review the advancements achieved so far, introduce the enhanced digital health in pharmacy course, and explore how this initiative aligns with FIP competency frameworks and recommendations.

Moderator: - Naoko Arakawa, Assistant Professor in International Pharmacy University of Nottingham, UK

Facilitator: - Genuine Desireh, FIP Educational partnerships and projects manager FIP, The Netherlands

Panellists: - Jaime Acosta, Community Pharmacist Farmacia Acosta, Spain 

Catherine Duggan FIP CEO FIP, The Netherlands 

Ardalan Mirzae - Barry A. Bleidt, Professor Barry and Judy Silverman College of Pharmacy Nova Southeastern University, USA

Michael Katz, Professor and Director of International Programs University of Arizona R. Ken Coit College of Pharmacy, USA

Dalia Bajis, FIP Senior programme lead FIP

Aukje Mantel-Teeuwisse, Professor of Pharmacy and Global Health, Utrecht University

Heart failure (HF) is often interconnected with other chronic diseases (including ischaemic heart disease, hypertension, diabetes, chronic kidney disease, atrial fibrillation, and obesity), creating a complex web of health considerations. The interconnectivity manifests in various ways, influencing identification, diagnosis, and treatment of these conditions. Community pharmacists and their teams are ideally placed to raise HF awareness, identify those at risk and be the driving force behind earlier detection and referral to primary care partners for screening, diagnosis and intervention. At this event, the “Heart Failure Pharmacy Toolkit” to support pharmacists in providing a range of HF pharmacy services will be presented.

This 2-day event will highlight the multifaceted roles of pharmacists and emphasise theirkey involvement in forming transdisciplinary partnerships with healthcare professionals,industry partners, and the community. Don’t miss out on keynote sessions and plenarylectures by renowned experts!
Non-PSS registrants from China and India are eligible for a 20% discount when registeringas a group with 10 or more members.

Important dates

• Abstract submissions for oral presentations, posters and workshops open: August 2024
• Early bird registration opens: October 2024